GlassScriptPhysician profile
Daniel Fitzgerald Gardner
NPI 1255863544
$14,053.81
in general payments reported to CMS, 2019-2025
14 companies · $4,339 in 2025
The $4,339 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.88 · 2022: $3,138 · 2023: $6,426 · 2024: $140 · 2025: $4,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,500 · Travel and Lodging: $879 · Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,500.00 |
| Travel and Lodging | $879.16 |
| Food and Beverage | $525.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,730.92 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $46.24 | 2023-2025 | Keytruda, Lynparza |
| Inari Medical, INC. | $29.85 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Vertex Pharmaceuticals Incorporated | $28.44 | 2025 | |
| Endo USA, INC. | $27.62 | 2025 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $26.03 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $25.81 | 2024 | Lynparza |
| Baxter Healthcare | $25.61 | 2023 | Tisseel |
| Bayer Healthcare Pharmaceuticals INC. | $24.98 | 2024 | |
| Tela Bio, INC. | $21.76 | 2024 | Ovitex 2s |
| Avita Medical Americas, LLC | $19.54 | 2024 | |
| Solventum Corporation | $18.52 | 2025 | Activ.A.C. |
| Tolmar, INC. | $17.61 | 2024 | |
| Boston Scientific Corporation | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.